FindMyKOL
Clinical trialNCT05004337CompletedObservational

Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies

SponsorNatera, Inc.Enrollment136Trisomy 13Trisomy 18Trisomy 21Vanishing Twin
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to collect blood samples from women carrying a vanishing twin pregnancy to further develop Natera's non-invasive prenatal screening test to provide information about possible chromosomal conditions for the living twin

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Center for Fetal Medicine & Women'S Ultrasound

    Los Angeles, California, United States

  • Stanford

    Palo Alto, California, United States

  • University of Colorado

    Aurora, Colorado, United States

  • Yale

    New Haven, Connecticut, United States

  • Christiana Care

    Newark, Delaware, United States

  • Emerald Coast Obgyn

    Panama City, Florida, United States

  • University of Kansas

    Kansas City, Kansas, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Beaumont

    Royal Oak, Michigan, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Hackensack

    Neptune City, New Jersey, United States

  • St. Peter'S University Hospital

    New Brunswick, New Jersey, United States

  • Nyu Long Island

    Mineola, New York, United States

  • Columbia University

    New York, New York, United States

  • Icahn School of Medicine at Mount Sinai Hospital

    New York, New York, United States

  • Nyu Langone

    New York, New York, United States

  • Weill Cornell Medicine

    New York, New York, United States

  • Montefiore Medical Center

    The Bronx, New York, United States

  • Lehigh Valley Health Network

    Allentown, Pennsylvania, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Cedar Health Research

    Irving, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Jul 2021
Primary completion
29 Nov 2023
Completion
29 Nov 2023
Last update posted
17 Aug 2026
Registered enrollment
136
Registry id
NCT05004337

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.